Biotech & Pharma

Malaria-Causing Plasmodium in Uganda Show Rapid Spread of Drug Resistance Mutations

22 sec read20 views0 listens

Researchers have identified new mutations in the malaria-causing parasite Plasmodium falciparum that decrease its susceptibility to common antimalarial drugs, including artemisinin-based therapies. This rapid spread of drug resistance in Uganda threatens current treatment efficacy and underscores the need for continuous surveillance and development of new antimalarial drugs.

Read the full article at Genetic Engineering News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Health & Medicine2 days ago29 sec read

STAT+: Pharmalittle: We're reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more

Regeneron Pharmaceuticals has received U.S. regulatory approval for Pasatru, a drug aimed at treating fibrodysplasia ossificans progressiva (FOP), a rare disease causing abnormal bone growth. Separately, Ultragenyx Pharmaceutical’s gene therapy Gengl...

Ali Nemati

Cybersecurity3 days ago26 sec read

HYDR8 Will Lead You to Water, But Will You Drink?

HYDR8 is a wearable device that monitors heart rate, oxygen levels, skin temperature, and environmental conditions to determine hydration stress and provide personalized recommendations. This tool addresses the common issue of neglecting hydration du...

Ali Nemati

Health & Medicine3 days ago25 sec read

STAT+: Pharmalittle: We're reading about an FDA commish nominee, mRNA cancer vaccine results, and more

President Trump is expected to nominate Heidi Overton, a key health policy advisor in his administration, as the next FDA commissioner. Additionally, a late-stage clinical trial shows that a personalized mRNA cancer vaccine, when combined with existi...

Ali Nemati